March 26, 2018 / 12:20 PM / 8 months ago

BRIEF-Armo Biosciences Announces Positive Outcome Of First Interim Analysis In Sequoia Phase 3 Pancreatic Cancer Study

March 26 (Reuters) - Armo Biosciences Inc:

* ARMO BIOSCIENCES ANNOUNCES POSITIVE OUTCOME OF FIRST INTERIM ANALYSIS IN SEQUOIA PHASE 3 PANCREATIC CANCER STUDY

* ARMO BIOSCIENCES INC - DMC RECOMMENDED THAT STUDY CONTINUE WITHOUT MODIFICATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below